WorldQuant Millennium Advisors’s AbbVie ABBV Stock Holding History

WorldQuant Millennium Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.9M	Sell	63,364 -472,913	-88%	-$102M	0.05%	264
2026 Q1	$117M	Sell	536,277 -265,519	-33%	-$58.9M	0.45%	55
2025 Q4	$183M	Buy	801,796 +88,941	+12%	+$20.3M	0.71%	27
2025 Q3	$165M	Sell	712,855 -422,179	-37%	-$86M	0.71%	30
2025 Q2	$211M	Buy	1,135,034 +612,702	+117%	+$114M	1.05%	18
2025 Q1	$109M	Buy	522,332 +105,981	+25%	+$20.6M	0.69%	33
2024 Q4	$74M	Sell	416,351 -161,765	-28%	-$29.7M	0.48%	55
2024 Q3	$114M	Buy	578,116 +348,697	+152%	+$65.1M	0.84%	25
2024 Q2	$39.3M	Buy	+229,419	New	+$38M	0.36%	87
2024 Q1	–	Sell	-253,194	Closed	-$39.2M	–	347
2023 Q4	$39.2M	Sell	253,194 -55,060	-18%	-$8.03M	0.55%	53
2023 Q3	$45.9M	Buy	308,254 +3,849	+1%	+$565K	0.71%	30
2023 Q2	$41M	Buy	+304,405	New	+$44.6M	0.69%	28
2021 Q3	–	Sell	-15,797	Closed	-$1.78M	–	318
2021 Q2	$1.78M	Buy	+15,797	New	+$1.78M	0.04%	255
2020 Q3	–	Sell	-162,377	Closed	-$15.9M	–	330
2020 Q2	$15.9M	Sell	162,377 -50,330	-24%	-$4.43M	0.37%	92
2020 Q1	$16.2M	Buy	212,707 +73,146	+52%	+$6.23M	0.39%	81
2019 Q4	$12.4M	Sell	139,561 -390,266	-74%	-$32.4M	0.24%	140
2019 Q3	$40.1M	Buy	529,827 +260,122	+96%	+$17.8M	0.78%	34
2019 Q2	$19.6M	Buy	269,705 +45,531	+20%	+$3.58M	0.37%	101
2019 Q1	$18.1M	Buy	224,174 +22,965	+11%	+$1.88M	0.43%	90
2018 Q4	$18.5M	Sell	201,209 -36,512	-15%	-$3.21M	0.55%	59
2018 Q3	$22.5M	Buy	237,721 +10,315	+5%	+$978K	0.75%	37
2018 Q2	$21.1M	Buy	+227,406	New	+$22.2M	0.81%	39

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WorldQuant Millennium Advisors's ABBV Position: Q2 2026 in Review

WorldQuant Millennium Advisors reduced its AbbVie (ABBV) stake by 88% in Q2 2026, selling an estimated $102M and leaving 63,364 shares worth $15.9M. The position accounts for 0.05% of the portfolio, ranked #264.

WorldQuant Millennium Advisors first reported a position in ABBV in Q2 2018 and has held it in 22 quarters since. The position peaked at $211M in Q2 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

WorldQuant Millennium Advisors held 63,364 shares of AbbVie worth $15.9M as of Q2 2026.
WorldQuant Millennium Advisors sold 472,913 AbbVie shares in Q2 2026, an estimated $102M.
AbbVie made up 0.05% of WorldQuant Millennium Advisors's portfolio in Q2 2026, its #264 holding.
WorldQuant Millennium Advisors first reported a position in AbbVie in Q2 2018 and has held it in 22 quarters since.
WorldQuant Millennium Advisors's AbbVie position peaked at $211M in Q2 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.